Differential characteristics of human 15-lipoxygenase isozymes and a novel splice variant of 15S-lipoxygenase
- PMID: 10542053
- DOI: 10.1046/j.1432-1327.1999.00818.x
Differential characteristics of human 15-lipoxygenase isozymes and a novel splice variant of 15S-lipoxygenase
Abstract
The lipoxygenases (LOs) are a family of nonheme iron dioxygenases that catalyse the insertion of molecular oxygen into polyunsaturated fatty acids. Five members of this gene family have been described in man, 5-LO, 12S-LO, 12R-LO, 15-LO and 15S-LO. Using partially purified recombinant 15S-LO enzyme and cells constitutively expressing this protein, we have compared the activity, substrate specificity, kinetic characteristics and regulation of this enzyme to that previously reported for 15-LO. 15S-LO has a threefold higher Km, similar Vmax and increased specificity of oxygenation for arachidonic acid, and a similar Km but decreased Vmax for linoleic acid in comparison to 15-LO. Unlike 15-LO, 15S-LO is not suicide inactivated by the products of fatty acid oxygenation. However, in common with other LOs, 15S-LO activity is regulated through calcium-dependent association of the enzyme with the membrane fraction of cells. In addition, whilst independently cloning the recently described 15S-LO, we identified a splice variant containing an in-frame 87-bp deletion corresponding to amino acids 401-429 inclusive. Modelling of the 15S-LO and subsequent studies with partially purified recombinant protein suggest that the deleted region comprises a complete alpha-helix flanking the active site of the enzyme resulting in decreased specificity of oxygenation and affinity for fatty acid substrates. Alternative splicing of 15S-LO would therefore provide a further level of regulation of fatty acid metabolism. These results demonstrate that there are substantial differences in the enzyme characteristics and regulation of the 15-LO isozymes which may reflect differing roles for the proteins in vivo.
Similar articles
-
Identification of amino acid determinants of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2.J Biol Chem. 2000 Jan 14;275(2):1287-93. doi: 10.1074/jbc.275.2.1287. J Biol Chem. 2000. PMID: 10625675
-
Probing the substrate alignment at the active site of 15-lipoxygenases by targeted substrate modification and site-directed mutagenesis. Evidence for an inverse substrate orientation.Biochemistry. 1998 Nov 3;37(44):15327-35. doi: 10.1021/bi9816204. Biochemistry. 1998. PMID: 9799493
-
Discovery of a second 15S-lipoxygenase in humans.Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6148-52. doi: 10.1073/pnas.94.12.6148. Proc Natl Acad Sci U S A. 1997. PMID: 9177185 Free PMC article.
-
Molecular cloning of a second human 15S-lipoxygenase and its murine homologue, an 8S-lipoxygenase. Their relationship to other mammalian lipoxygenases.Adv Exp Med Biol. 1999;447:29-36. doi: 10.1007/978-1-4615-4861-4_3. Adv Exp Med Biol. 1999. PMID: 10086180 Review. No abstract available.
-
Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications.Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:263-90. doi: 10.1016/s0090-6980(02)00035-7. Prostaglandins Other Lipid Mediat. 2002. PMID: 12432923 Review.
Cited by
-
Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology.Front Pharmacol. 2022 Nov 9;13:1042420. doi: 10.3389/fphar.2022.1042420. eCollection 2022. Front Pharmacol. 2022. PMID: 36438817 Free PMC article. Review.
-
CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration.Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):809-15. doi: 10.1161/ATVBAHA.109.185777. Epub 2009 Apr 2. Arterioscler Thromb Vasc Biol. 2009. PMID: 19342597 Free PMC article.
-
Novel pyrazole carboxylate derivatives as lonazolac bioisosteres with selective COX-2 inhibition: design, synthesis and anti-inflammatory activity.Mol Divers. 2025 May 22. doi: 10.1007/s11030-025-11220-8. Online ahead of print. Mol Divers. 2025. PMID: 40405028
-
Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.Neoplasia. 2003 Mar-Apr;5(2):121-7. doi: 10.1016/s1476-5586(03)80003-9. Neoplasia. 2003. PMID: 12659684 Free PMC article.
-
Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer.Cell Cycle. 2014;13(11):1798-810. doi: 10.4161/cc.28757. Epub 2014 Apr 14. Cell Cycle. 2014. PMID: 24732589 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases